Fig. 6 | Scientific Reports

Fig. 6

From: Dual redox effects of 2,6-bis-(4-hydroxyl-3-methoxybenzylidene) cyclohexanone (BHMC) on human liver cancer cells, HepG2 via ROS, glutathione and Nrf2/Keap1 pathway

Fig. 6

GSH: GSSG ratio in HepG2 cells treated with BHMC and curcumin at 18 and 24 h. The ratios were quantified using commercial kits according to the manufacturer’s instructions. Data are presented as mean ± S.E.M. and represent of three independent experiments. Statistically significant differences are indicated with *p < 0.05; **p < 0.01 of treatment groups by using One-way ANOVA followed by Dunnett’s post hoc tests compared to untreated group.

Back to article page